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Abstract
Purpose Intensity-modulated radiation therapy (IMRT) has
changed radiation treatment of head and neck cancer (HNC).
However, it is still unclear if and how IMRT changes oral
morbidity outcomes. In this prospective study, we assessed
the outcome of reducing post-IMRT sequelae by means of
pre-radiation dental screening and eliminating oral foci.
Methods All consecutive dentate patients > 18 years, diag-
nosed with primary oral or oropharyngeal carcinoma, referred
for pre-treatment dental screening between May 2011 and
May 2013, were included and followed for 2 years. Patients
were treated with IMRT or IMRT with chemotherapy
(CHIMRT). Dental screening data, demographic data, and da-
ta on oral sequelae during follow-up were recorded.
Diagnosed oral foci were treated before start of the radiation
therapy.
Results Oral foci were found in 44/56 (79%) patients,
consisting predominantly of periodontal breakdown. Bone
healing problems after radiotherapy occurred more often in
patients with periodontal pockets ≥ 6 mm at baseline (19 vs.
4% in patients with pockets < 6 mm). Osteoradionecrosis
developed in 4/56 patients (7%) during follow-up. In line with
this observation, multiple logistic regression analysis showed
that the periodontal inflamed surface area, which is higher in
patients with more severe periodontal disease, predicted that a
patient has a higher risk on developing osteoradionecrosis or
bone healing problems (p = 0.028).
Conclusions Patients with severe periodontal disease before
IMRT/CHIMRT are more prone to develop bone healing
problems post-radiotherapy.
Keywords Head and neck cancer . Intensity-modulated
radiotherapy . Chemoradiotherapy . Dental focal infection .
Osteoradionecrosis . Periodontitis
Introduction
Head and neck cancer (HNC) patients treated by radiotherapy
are at risk of developing severe oral sequelae. Periodontal
disease, an inflammatory disease affecting the tissues sur-
rounding the teeth resulting in inflammation of the gums and
loss of bone adjacent to the affect teeth, and radiation-
associated dental caries may require dental extractions and
consequently result in an increased risk of developing
osteoradionecrosis (ORN) of the jaw [1–4]. ORN is
radiation-induced destruction of the bone. ORN is difficult
to treat, not self-limiting, and may require extensive invasive
surgery and/or adjuvant treatment with hyperbaric oxygen
(HBO). Hypovascularity and hypocellularity of irradiated tis-
sues are considered the predominant underlying patho-
physiologic mechanisms, which have low reparative ability
[5, 6]. The majority of ORN cases develop within 3 years after
radiotherapy [7].
Risk factors for developing ORN include post-irradiation
extractions [1], periodontal attachment loss/periodontitis [2],
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oral surgical interventions [8], and poor dental status
[9]. To prevent oral morbidity after radiotherapy, in par-
ticular ORN, pre-radiation dental screening is commonly
performed to locate and eliminate oral foci, although the
efficacy of these interventions is unclear [3]. An oral
focus is defined as a pathologic process in the oral
cavity that does not cause major problems in healthy
individuals, but may lead to severe local or systemic
inflammation under certain circumstances [1, 10].
During the last decade, treatment of HNC has
changed substantially, particularly due to the introduc-
tion of intensity-modulated radiation therapy (IMRT)
and concomitant chemoradiation [11]. The effects of
IMRT on oral tissues and jaw bone in particular are
not yet clearly understood. IMRT results in less reduc-
tion of salivary flow due to sparing of the parotid and/
or submandibular glands [12]. However, dose redistribu-
tion resulting from salivary gland sparing may lead to
higher doses to other tissues in the radiation field, in
particular to the oral mucosa, which can result in Bbeam
path toxicities^ [13]. These potentially higher doses to
jaw bone and oral tissues entail a higher risk of devel-
oping ORN post-radiotherapy [6].
Current pre-radiation dental screening protocols are
based on conventional radiotherapy and require an up-
date to take account of the IMRT effects. We therefore
conducted a prospective 2-year follow-up cohort study
to assess the outcome of pre-radiation dental screening
and elimination of oral foci in HNC patients treated
with IMRT. Results were compared to those of histori-




All consecutive dentate or partially dentate patients > 18 years,
diagnosed with primary oral or oropharyngeal carcinoma, re-
ferred to the University Medical Center Groningen (UMCG),
the Netherlands, for pre-treatment dental screening between
May 2011 and May 2013, were included if IMRT to the head
and neck region was part of the treatment plan. Patients who
had undergone previous oncologic treatment (surgery and/or
radiotherapy and/or chemotherapy) to this region were ex-
cluded as well as patients with unknown primary or parotid
gland tumors. A standardized follow-up of 2 years’ post-
oncologic treatment related to oral and dental morbidity was
completed (JMS). Written informed consent was obtained
from all patients. The medical ethical committee of the
UMCG approved the study (METC 2012/091).
Dental screening
All patients were evaluated before their oncologic treatment as
part of routine clinical practice by means of oral and dental
screening, including radiographic examination [14]. Plaque
and bleeding scores were assessed as a percentage of the total
number of sites with plaque respectively bleeding on probing.
To quantify periodontal disease, the periodontal inflamed sur-
face area (PISA) was used [15]. Patients were asked about
their smoking and drinking habits. Self-reported smoking op-
tions were Bcurrent smoker,^ Bpast smoker,^ or Bnever
smoked.^ Self-reported alcohol consumption options were
Bnever drink alcohol^ or Bdrink alcohol.^
All data obtained at baseline and follow-up visits (Table 1)
were collected in pre-determined order and recorded using a
standardized study form.
IMRT
All included patients were subjected to definitive primary or
postoperative IMRT or definitive primary or postoperative
chemoradiation (CHIMRT). Patients treated with concomitant
CHIMRT were irradiated with a conventional fractionation
schedule (2 Gy per fraction, five times per week up to
70 Gy in 7 weeks). In case of primary radiotherapy of tumors
considered ineligible for CHIMRT, an accelerated schedule
(six times per week) with concomitant boost technique was
used, either or not combined with cetuximab. IMRT treat-
ments attempted to spare the parotid glands without
compromising dose to target volumes. In general, 7-field equi-
distant, non-opposing beams were applied. All IMRT treat-
ments applied a simultaneous integrated boost. Most patients
received bilateral elective irradiation of the neck nodes to a
total dose of 54.25 Gy, in fractions of 1.55 Gy. Primary tumor
and pathological lymph nodes were treated to a total dose of
70 Gy, in 2 Gy fractions.
If applied, chemotherapy was given concurrently with frac-
tionated IMRT and consisted of Carboplatin on day 1 (300–
350 mg/m2 in 30 min intravenously) and 5-fluorouracil (5-
FU) from day 1 to 4 by continuous infusion (600 mg/m2/
24 h), consisting of three courses given with an interval of
3 weeks. Postoperative chemotherapy consisted of
6 × 50 mg Cisplatin weekly. When chemotherapy was con-
sidered to be infeasible, patients were treated with cetuximab
using a loading dose of 400 mg/m2 1 week prior to radiother-
apy and a weekly dose of 250 mg/m2 during radiotherapy.
Treatment of oral foci
Before onset of IMRT or CHIMRT, oral foci were eliminated
(Table 2), if teeth related to the foci were within the radiation
field receiving a cumulative dose > 40 Gy. An oral focus was
defined as follows [3]:
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& severe dental caries in which excavation may lead to pulp-
al exposure;
& severe periodontal disease, defined as pockets on probing
≥ 6 mm, furcation ≥ grade 1, mobility > grade 1, gingival
recession ≥ 6 mm, and especially a combination of these
periodontal problems;
& non-restorable teeth with large restorations, especially
those extending beyond the gum line or with root caries,
or those with severe erosion or abrasion;
& periapical pathosis and non-vital teeth;
& impacted, partially impacted, or partially erupted teeth not
fully covered by bone or showing radiolucency;
& cysts and other radiographic abnormalities.
Dental pathology not defined as an oral focus was treated
according to professional dental standards. Before the onset of
IMRT or CHIMRT, patients were seen by a dental hygienist
for dental prophylaxis and oral hygiene instructions.
Oral care during radiotherapy
During IMRT and CHIMRT, patients were seen daily
(Monday to Friday) by a dental hygienist for spraying the oral
cavity with saline according to standard protocol [16].
Instructions were given to continue normal daily oral care
(tooth brushing and/or interdental cleaning) as long as possi-
ble, and to rinse the mouth with salt-baking soda solution at
home, 8–10 times per day [14]. Dentate IMRT and CHIMRT
patients received custom-made fluoride trays and were pre-
scribed a neutral 1% sodium fluoride gel to be used every
second day [14, 17, 18].
Follow-up
Regular oncology follow-up visits to the oral and maxillofacial
surgeon, dental hygienist, and/or hospital dentist were combined
with visits to the researcher (JMS) (Table 1). Dental follow-up by
the dental hygienist and hospital dentist is standard for IMRTand
CHIMRT patients every 3–6 months, depending on the patient’s
needs, during at least 5 years after treatment. Oral sequelae dur-
ing follow-up were recorded, including caries and restorative
problems, periodontal disease, bone healing problems, and
ORN. According to the prevailing definition, ORN is an area
of exposed devitalized irradiated bone that fails to heal over a
period of 3 months in the absence of local neoplastic disease [5,
19–21]. All other phenomena of a delayed bone healing, such as
bone sequestration after radiation and areas with non-healing
bone after tooth extraction less than 3 months, were defined as
bone healing problems. Antibiotic prophylaxis was given in case
of surgical intervention and, if the dose in the specific region of
surgical treatment was ≥40 Gy, application of HBO was consid-
ered depending on patient factors, such as smoking, general
health, and complexity of removal of affected teeth. Moreover,
when oral sequelae occurred during follow-up and if they were
within the radiation field (≥ 40 Gy), all efforts were made to
prevent tooth extraction. All data (dental screening and follow-
up visits) were recorded using the standardized study form.
Historical control group
The historical control group consisted of 80 adult HNC pa-
tients who had been subjected to pre-radiation dental screen-
ing for oral foci. They received postoperative or primary cu-
rative three-dimensional conformal radiation therapy or che-
moradiation, as part of primary cancer treatment for carcino-
ma in the oral cavity or oropharynx [2].
Statistical analysis
Data were analyzed using IBM SPSS Statistics 23.0 for
Windows. Values of p < 0.05 were considered signifi-
cant. Testing for significance was done using Chi-square
tests for binary data (developing ORN, having bone
healing problems) and Kruskal-Wallis tests for quantita-
tive data (PISA). The Wilcoxon signed rank test was
used for comparing baseline PISA scores with follow-
up data.
Age at dental screening, smoking and alcohol use at base-
line, treatment applied for foci elimination, pocket depth
≥ 6 mm, PISA score, T-stage, radiotherapy dose, conventional
or accelerated radiotherapy, surgical treatment, and chemo-
therapy were explored for their predicted value influencing
the development of ORN or bone healing problems at the
follow up assessment with multiple logistic regression analy-
sis. Variables that were significantly associated with the out-
come variable (p ≤ 0.10) were entered in the logistic regres-
sion analyses. Variables not significantly contributing to the
regression equation were removed (p > 0.10).

















Panoramic X-ray X X
General health and
medication
X X X X
Alcohol/Tobacco X X X X






IMRT intensity modulated radiation therapy, CHIMRT IMRT with
chemotherapy
Support Care Cancer (2018) 26:1133–1142 1135
Results
Demographics
Between May 2011 and May 2013, 56 patients met the
inclusion criteria (Fig. 1). Follow-up ranged from 11 to
27 months, with a median of 24 [22; 24] months
(Fig. 2). Demographics, clinical characteristics, and
baseline dental data of all patients are summarized in
Table 3.
After dental screening and pre-radiation treatment of foci,
5/56 patients needed a full mouth clearance (Fig. 1). Results
on oral sequelae during follow-up are therefore based on the
remaining 51 dentate patients. Results on dental screening and
bone healing problems are based on the original 56 patients.
Dental screening and treatment of oral foci
Out of 56 dentate patients, 44 (79%) had 1 or more oral foci at
dental screening (Fig. 3). Baseline periodontal condition was
healthy (no pockets) in 3 patients. Pocket depths of 4–5 and
≥ 6 mm were found in 25 and 28 patients, respectively. Thus,
53/56 patients (95%) had periodontal disease to some extent at
baseline. Median pre-treatment PISAwas 349mm2 [131; 863]
(Table 3).
Table 2 Assessment and
treatment of oral foci within or
outside the radiation field
Assessed tooth problems Treatment if cumulative dose > 40Gya Treatment if cumulative dose < 40 Gy
or outside the radiation portala
Caries profunda Tooth extraction Restoration, if necessary combined with





In teeth without root canal filling: endodontic
treatment and/or apexification
In teeth with root canal filling:
endodontic re-treatment,
apexification, or tooth extraction
(needed in case of pre-radiotherapy
time limitations)
In teeth without root canal filling: endodontic
treatment
In teeth with root canal filling:
endodontic re-treatment,
apexification, or tooth extraction




with periodontal disease, in
afunctional teeth or with
symptoms
Tooth extraction In teeth without root canal filling: endodontic
treatment combined with initial periodontal
treatment
In teeth with root canal filling:
endodontic re-treatment,
apexification, or tooth extraction
depending on the prognosis
Avital pulp with symptoms
without periapical
radiolucency on radiographs
Endodontic treatment or tooth extraction
(which might be necessary in case of
pre-radiotherapy time limitations)
Endodontic treatment or tooth extraction
depending on the prognosis
Avital pulp without symptoms
and without periapical
radiolucency on radiographs
Endodontic treatment or tooth extraction
(needed in case of pre-radiotherapy time
limitations)
Endodontic treatment
(which can be postponed until after
radiotherapy)
Periodontal disease with: Pockets
4–5 mm








Only recession requires no treatment
Impacted teeth or roots fully
covered by bone without
radiographic abnormalities
No treatment
If problems are expected in the future:
tooth extraction
No treatment
Impacted teeth or roots not fully




Tooth extraction No treatment or, in case of symptoms, surgical
removal
Roots with periapical radiolucency
might be worth preserving by
endodontic treatment and restoration
(which can be postponed until after
radiotherapy)
Cysts Surgical removal Surgical removal
Internal or external root
resorption
Tooth extraction Endodontic treatment or tooth extraction
depending on the prognosis
a If an irradiated patient needed treatment, radiation fields were always verified with the department of Radiation
Oncology, and depending on the dose in the specific region where treatment was needed, antibiotic prophylaxis
was given to the patient
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Pre-radiotherapy dental extractions were needed in 43 pa-
tients, viz., for 1 patient with no pockets, in 15 patients with
pockets 4–5mm, and 27 in patients with pockets ≥ 6mm. Five
patients (11%) needed full mouth clearance: 4 patients had
generalized severe periodontitis with pockets ≥6 mm, and 1
patient never visited a dentist because of anxiety. A median of
seven teeth [2; 10] were extracted per patient. One patient had
a dental cyst that was surgically removed. After focus elimi-
nation, the periodontal condition was healthy in 3 patients,
while 48 dentate patients had remaining pockets of 4–5 mm.
Oral sequelae during follow-up
Oral hygiene and fluoride prophylaxis
All dentate patients were instructed to brush their teeth daily
and to use fluoride gel every other day during follow-up.
Comparing baseline and 2 years of follow-up, plaque scores
reduced from a median of 50 to 30% (p = 0.016) and bleeding
scores from 30 to 10% (p = 0.027).
Post-radiotherapy periodontal health
Post-radiotherapy, 12/51 dentate patients (24%) had progres-
sion of periodontal pocket depth (4–5 mm pockets deepened)
and/or developed new periodontal pockets (≥ 4 mm on a site
that was ≤ 3 mm before). Eight out of these 12 patients needed
tooth extraction after dental screening before radiation be-
cause of pockets ≥ 6 mm, and all 12 had remaining pockets
of 4–5 mm (not considered as oral foci that needed extraction)
before the onset of radiotherapy.
PISA scores decreased significantly during follow-up from
349 mm2 [131; 863] at baseline to 225 mm2 [139; 408]
(p = 0.006) and 149 mm2 [77; 357] (p = 0.003, Table 3) at
6 months and 2 years follow-up, respectively, probably due to
elimination of oral foci and improved oral hygiene.
Post-radiotherapy tooth extractions
Six patients (12%) needed one to three post-radiotherapy tooth
extractions because of deep dental caries (n = 4) or periodontal
disease (n = 2).
Fig. 2 Kaplan Meier plot of
follow-up in months. Nine
patients dropped out before the
end of the study: two were lost to
follow-up, two patients died, and
five patients were diagnosed with
metastatic or recurrent disease
and declined health care
Patients included 
in the study n=56














Fig. 1 Flow chart of included patients showing dentate and edentate
patients
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Post-radiotherapy dental caries
Out of 51 dentate patients, 13 (25%) developed 1 or more
carious lesions.
Post-radiotherapy periapical pathosis
Out of 51 patients, 3 patients (6%) developed deep dental
caries with periapical pathosis during follow-up. Endodontic
treatment or tooth extraction was performed.
Post-radiotherapy bone healing problems and ORN
None of the 3 patients without periodontal pockets at baseline
developed bone healing problems or ORN during 2-year fol-
low-up.
Bone healing problems were observed in 10 out of 56 pa-
tients (18%) in the mandible: 3 patients were diagnosed with
delayed wound healing after pre-radiotherapy tooth extrac-
tion, 3 with lingual mandibular sequestration (unrelated to
tooth extraction), and 4 with ORN (more details below). Of
Table 3 Demographics, clinical
characteristics, and baseline
dental data of the study group
(n = 56)
Variable Category Number of patients
dentate during follow-up
Total n = 51
Number of patients
edentate during follow-upa
Total n = 5
Demographics Age, years Mean (SD) 59 (8.5) 62 (5.4)




Tumor site Oral cavity 25 1
Oropharynx 26 4




Not reported 1 0




Not reported 1 0
Cumulative
IMRT dose




















Wound closure Primary 9 0














Median [IQR] 24 [18–27] 11 [8.5–17]
Plaque score Median [IQR] 50 [25–75] 70 [45–80]
Bleeding score Median [IQR] 30 [20–60] 70 [33–95]
PISA Median [IQR] 349 [131–863] 533 [170–1509]
DMFS Median [IQR] 77 [60–102] 118 [88–120}
SD standard deviation, IQR inter quartile range, IMRT intensity modulated radiation therapy, CHIMRT intensity
modulated radiation therapy with chemotherapy,DMFS decayed missing filled surfaces. The range of scores is 0–
128, NR not reported
a After dental screening and pre-radiation treatment of oral foci, five patients needed a full mouth clearance
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these 10 patients, 1 patient developed bone healing problems
after pre-radiotherapy full mouth clearance. The other 9 pa-
tients had teeth left after elimination of oral foci and during the
2 years of follow-up.
In the group of patients with baseline periodontal pockets
≥ 6 mm (n = 28), 5 developed bone healing problems, not yet
diagnosed as ORN, during follow-up (19%) and 1 patient
(4%) in the group with pocket depths of 4–5 mm at baseline
(n = 25). No increased risk for developing bone healing prob-
lems was found in patients with periodontal pockets ≥ 6mm at
baseline compared to patients with pockets < 6 mm at base-
line, although there was strong tendency pointing in this di-
rection (p = 0.084).
Of the 28 patients with periodontal pockets ≥ 6 mm at
baseline, 2 developed ORN (7%) as well as in 2 out of 25
patients with pockets < 6 mm at baseline (8%). Therefore in
our study, no increased risk for developing ORN was found in
patients with periodontal pockets ≥ 6 mm at baseline com-
pared to patients with pockets < 6 mm at baseline (p = 1.000).
ORN developed in 1 patient, 3 months after completion of
postoperative IMRT in an area where a severely periodontal
compromised mandibular molar was removed before radio-
therapy. In a second patient, ORN developed, 7 months after
postoperative CHIMRT. Extended caries developed in the
most distal mandibular molar in this patient. Endodontic treat-
ment was impossible to perform and the molar was extracted
post-radiotherapy resulting in a non-healing socket and even-
tually ORN. This patient was free of oral foci at baseline, but
had pockets of 4–5 mm at baseline.
Idiopathic ORN of the angle of the mandible resulting in a
pathologic fracture developed in 1 patient 2 months after
CHIMRT had ended. This patient was free of periodontal
disease during follow-up. In another patient, ORN was unre-
lated to pre- or post-radiotherapy tooth extractions, as it was
observed 2 months after postoperative IMRT in the
transplanted fibula bone used for reconstruction of the mandi-
ble. The patient had post-radiotherapy surgery, however, to
remove reconstruction plates. This patient had periodontal
pockets 4–5 mm at baseline.
Many factors might influence development of bone healing
problems after radiotherapy. Patients with (n = 10) and with-
out (n = 46) bone healing problems were compared for num-
ber of teeth extracted after dental screening (p = 0.052), num-
ber of teeth at dental screening (p = 0.357), T-stage
(p = 0.093), having diabetes (p = 0.186), smoking at baseline
(p = 0.755), drinking alcohol at baseline (p = 0.275), baseline
plaque (p = 0.949), bleeding (p = 0.355) and PISA scores
(p = 0.072), and having periodontal pockets ≥ 4 mm
(p = 0.406) or ≥ 6 mm at dental screening (p = 0.163).
Multiple logistic regression analysis
Multiple logistic regression analysis showed that of the vari-
ables assessed (see section on statistical analysis), only the
PISA score predicted a higher risk on developing ORN or
bone healing problems.
Comparison historical control group
Comparison with historical controls [2], on baseline, showed
no difference for the presence of oral foci (75 vs. 79%;
p = 0.630), patient with pockets depths ≥ 6 mm (54 vs.
Fig. 3 Oral foci were found in 44 out of 56 patients. Since patients were occasionally diagnosed with more than one oral focus, the sum of the numbers
exceeds 44. Patients had one to six oral foci with a mean of 2.3 foci per patient (SD = 1.1)
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50%; p = 0.668), and extractions (average of 7.7 extracted
teeth vs. 7.0; p = 0.266). In this study, 7% of the patients
developed ORN compared to 11% of the historical controls
(p = 0.424).
Discussion
This study showed that patients with periodontal disease be-
fore IMRT/CHIMRT are prone to develop bone healing prob-
lems post-radiotherapy. The assessed protocol for elimination
of oral foci pre-IMRTwas compared to historical controls with
conventional radiotherapy [2]; the protocol was equally effec-
tive for patients treated with IMRT/CHIMRT. Post-
radiotherapy oral and dental morbidity seen in IMRT/
CHIMRT patients is comparable to that seen in patients treat-
ed with conventional radiotherapy.
Periodontal inflamed surface area
The relationship between periodontal disease and bone
healing problems is supported by our finding that baseline
PISA scores predicted a higher risk on developing ORN or
bone healing problems. Presence of periodontal pockets
≥ 6 mm at dental screening was different between patients
with and without bone healing problems, although not signif-
icant. There seems to be a strong trend, however, and our
study may have been underpowered to find a significant dif-
ference. The correlation of PISA with ORN deserves further
study.
Oral foci
Compared to our retrospective study [2] that included 80 pa-
tients subjected to conventional radiotherapy (mean follow-up
26 months), a comparable percentage of patients presented
with oral foci. Again, oral foci consisted mainly of periodontal
disease, which is comparable to the percentage of patients
with periodontal problems (68%) in the small study of
Bueno et al. [22]. Approximately 10% of Dutch adults have
severe periodontal disease [23]. Apparently, poor periodontal
health is more common among HNC patients [2, 4, 24, 25]
and might be a major cause of bone-related oral sequelae post-
radiotherapy.
Bone healing problems and ORN
Bone healing problems were observed in 10/56 patients
(18%). We diagnosed 5 patients with delayed wound healing
and 1 with lingual mandibular sequestration, which was not
defined as ORN because healing occurred within 3 months
after minimally invasive surgery (sequestrectomy). Immediate
surgical intervention in case of exposed bone, as done in our
hospital, may result in a more rapid healing compared to
observation.
ORN was reported in 7% of our patients after IMRT com-
pared to 11% in our retrospective three-dimensional confor-
mal radiation therapy (3D-CRT) study [2]. The prevalence of
ORN as reported in the literature is highly variable [7] and the
reported outcomes on occurrence of ORN after IMRT are
limited. Our findings suggest a reduced rate of ORN following
the clinical introduction of IMRT [26–28]. It has been sug-
gested, however, that the latency time to develop jaw compli-
cations after IMRT is longer. Nevertheless, after 3 years, the
risk of developing jaw complications appears to be equal to
that for non-IMRT treatment [29]. Nabil et al. [7] suggested a
median/mean follow-up of > 3 years, since 90% of ORN cases
were reported within 3 years after radiotherapy. Our median
follow-up was shorter than in the studies referred to, and more
cases of ORN may develop in our cohort in the future.
However, all cases of ORN in this study occurred in the first
7 months after IMRT.
Studer et al. [26] reported 5 cases of ORN in 304 patients
(1.6%) with oropharyngeal or oral cavity carcinoma treated
with IMRT, with a follow-up between 5 and 86 months [26].
Gomez et al. [28] included 168 patients with a follow-up be-
tween 0.8 and 89.6 months; they reported a low incidence of
ORN (1%). However, 54% of the included patients in the
latter study had a tumor located outside the oral cavity or
oropharynx, resulting in a lower radiation dose to the jaws,
which might be accompanied by a lower incidence of ORN.
Both studies did not report how many patients received post-
operative or primary IMRT, which may have influenced the
outcomes on ORN since it is a known risk factor [8]. A com-
plete lack of ORN was reported by Ben-David et al. [27].
They suggested that the reduction in the ORN rates could be
attributed to more conformal dose distributions and to better
prophylactic care and ongoing dental care.
Our oral care protocol was similar for our retrospective and
prospective study, although it was more strictly executed pro-
spectively, with only 1 patient that was not treated according
to protocol compared to 15 patients in the retrospective study
[2]. Those 15 patients received pre-radiotherapy initial peri-
odontal therapy for teeth with pockets ≥ 6 mm, instead of
tooth extraction, and they were particularly at risk of develop-
ing ORN. The improved implementation of the dental screen-
ing protocol may have decreased our ORN prevalence, as
suggested by others [27], and this might explain the weaker
relationship between periodontal disease and ORN found in
the present study compared to the retrospective study [2].
Nevertheless, periodontal disease, derived as PISA scores, is
still the only factor that we found to be associated with bone
healing problems.
Periodontal treatment might have a short-term (6 months)
positive effect on periodontal breakdown [22], but the present
study (median follow-up 24 months) showed that progression
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of periodontal pocket depth was frequently observed after
IMRT (24%). This percentage is even higher than the 18%
reported in the retrospective study [2].
In our study on oral microflora [30], we found an almost
immediate effect after the elimination of oral foci, with a de-
crease of periodontal pathogens. However, rather high per-
centages of periodontal pathogens were still present in our
HNC patients 1 year after IMRT and may be involved in
progression of pocket depths.
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Conclusion
This study showed that patients with severer periodontal dis-
ease present before IMRT/CHIMRT, i.e., a higher PISA, were
more prone to develop bone healing problems post-radiother-
apy. Furthermore, it was shown that post-radiotherapy oral
and dental morbidity seen in IMRT/CHIMRT patients was
comparable to that of patients treated with three-dimensional
conformal radiation therapy under the condition of pre-
radiation screening and treatment of oral foci.
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